According to pharmacists, the Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring—heavily impacting independent drugstores, which is...
According to pharmacists, the Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring—heavily impacting independent drugstores, which is...
According to pharmacists, the...